乙基3-(4-异丁基苯基)丙酸酯 | 230287-81-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 乙基3-(4-异丁基苯基)丙酸酯
• 英文名称: Ethyl 3-[4-(2-methylpropyl)phenyl]propanoate
• CAS: 230287-81-7
• 化学式: C₁₅H₂₂O₂
• 分子量: 234.338
• InChiKey: HQCIUZLBNNCORC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  乙基3-(4-异丁基苯基)丙酸酯 在 胍基乙酸 、 一水合肼 作用下， 生成 N-[(5-chloro-3-methyl-1-phenylpyrazol-4-yl)methylideneamino]-3-[4-(2-methylpropyl)phenyl]propanamide
  参考文献：
  名称：

  Pharmacological screening for anti-inflammatory, analgesic activity of pyrazolyl derivatives along with molecular docking studies

  摘要：

  The pyrazole derivatives were synthesized and pharmacologically evaluated for analgesic (tail flick) and anti-inflammatory (based on carrageenan-induced paw edema) activities. Compound 4k showed high potency as an anti-inflammatory agent after 3 and 4-h time intervals (P < 0.001) equipotent to indomethacin. They were devoid of ulcerogenic potential when administered at a dose of 30 mg/kg. The compounds, which showed less ulcerogenic action, also showed reduced malondialdehyde content (MDA), which is one of the byproduct of lipid peroxidation. Further docking studies of titled compounds was done to understand key interactions responsible for observed inhibition of COX enzyme. The most active compound 4k was found to have -11.192 kcal/mol, as the free energy of binding. Various other key interactions between the synthesized molecules and active site of COX-2 enzyme, responsible for the obtained pharmacological results were also reported. Most of the active compounds were docked well into the active sites of the receptor.

  DOI：

  10.1007/s00044-011-9901-0
• 作为产物：
  描述：

  (E)-ethyl 3-(4-isobutylphenyl)acrylate 在 RuCl₂(2-(diphenylphosphino)-N-(2-(n-butylthio)ethyl)ethanamine)PPh₃ 、 potassium methanolate 、 氢气 作用下， 以 四氢呋喃 为溶剂， 105.0 ℃ 、5.0 MPa 条件下， 反应 16.0h， 以82%的产率得到乙基3-(4-异丁基苯基)丙酸酯
  参考文献：
  名称：

  IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS

  摘要：

  在存在包含氮、硫和磷原子的三齿或双齿配体的过渡金属配合物的情况下，对含有碳杂原子双键的底物进行氢化的过程，其中至少N和P原子，以及可选地也包括S原子与过渡金属配体形成配位键。

  公开号：

  US20160326199A1

文献信息

• HETEROCYCLIC CETP INHIBITORS
  申请人：Salvati E. Mark

  公开号：US20070161685A1

  公开（公告）日：2007-07-12

  Compounds of formula Ia and Ib wherein A, B, C and R 1 are described herein.

  式Ia和Ib的化合物 其中A、B、C和R1 如本文所述。
• N-((3-BENZYL)-2,2-(BIS-PHENYL)-PROPAN-1-AMINE DERIVATIVES AS CETP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES
  申请人：Salvati Mark E.

  公开号：US20100041717A1

  公开（公告）日：2010-02-18

  Compounds of formula (Ia) and (Ib), wherein A, B, C, R 1 and R 14 are described herein.

  式(Ia)和(Ib)的化合物，其中A、B、C、R1和R14如本文所述。
• [EN] IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS<br/>[FR] PERFECTIONNEMENTS APPORTÉS À DES COMPOSÉS ORGANIQUES OU EN RELATION AVEC CEUX-CI
  申请人：GIVAUDAN SA

  公开号：WO2015110515A1

  公开（公告）日：2015-07-30

  A process for the hydrogenation of a substrate comprising a carbon heteroatom double bond in the presence of a transition metal complex comprising a tridentate or bisdentate- ligand containing a nitrogen, sulphur and phosphorus atom, of which at least the N- and P- and optionally also the S-atom coordinates with the transition metal.

  在存在包含氮、硫和磷原子的三齿或双齿配体的过渡金属配合物的情况下，对含有碳杂原子双键的底物进行氢化的方法，其中至少N和P原子以及可选的S原子与过渡金属配位。
• Ligand-enabled palladium-catalyzed hydroesterification of vinyl arenes with high linear selectivity to access 3-arylpropanoate esters
  作者：Zhixin Deng、Sheng Han、Miaolin Ke、Yingtang Ning、Fen-Er Chen

  DOI：10.1039/d2cc00228k

  日期：——

  Palladium-catalyzed linear-selective hydroesterification of vinyl arenes with alcohols enabled by diphosphine ligands derived from bis[2-(diphenylphosphino)ethyl]amides has been developed. A variety of 3-arylpropanoate esters were obtained in high yields and regioselectivity. The robustness of this methodology was further demonstrated by the efficient gram-scale synthesis of the ethyl 3-phenylpropanoate

  已经开发了由衍生自双[2-(二苯基膦基)乙基]酰胺的二膦配体实现的乙烯基芳烃与醇的钯催化线性选择性加氢酯化反应。以高产率和区域选择性获得了多种 3-芳基丙酸酯。3-苯基丙酸乙酯作为氢化肉桂酸前体的有效克级合成进一步证明了该方法的稳健性。
• HOMO- AND HETEROCYCLIC COMPOUNDS SUITABLE AS CETP INHIBITORS
  申请人：Bristol-Myers Squibb Company

  公开号：EP1954668B1

  公开（公告）日：2011-09-28